Viewing Study NCT06305702


Ignite Creation Date: 2025-12-25 @ 4:03 AM
Ignite Modification Date: 2025-12-26 @ 2:58 AM
Study NCT ID: NCT06305702
Status: COMPLETED
Last Update Posted: 2024-03-12
First Post: 2024-03-05
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Real-world Study of Inetetamab in HER2-positive Metastatic Breast Cancer
Sponsor: Liaoning Cancer Hospital & Institute
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module